Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial
Bianca Grosser, Jake Emmerson, Nic G. Reitsam, David Cunningham, Matthew Nankivell, Ruth E. Langley, William H. Allum, Martin Trepel, Bruno Maerkl*, Heike I. Grabsch*
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial'. Together they form a unique fingerprint.